Healthcare Industry News: Cook
News Release - March 28, 2011
Cantata(TM) Superselective Microcatheter Broadens Cook Medical’s Line of Embolization ProductsNew microcatheter demonstrates company’s commitment to driving innovation in interventional radiology
CHICAGO--(Healthcare Sales & Marketing Network)-- Committed to advancing the field of interventional radiology, Cook Medical today unveiled its Cantata™ Superselective Microcatheter at the Society of Interventional Radiology’s 36th Annual Scientific Meeting. Engineered to complement Cook’s portfolio of minimally invasive embolization products and coils, the Cantata offers a combination of support and torqueability to help interventional radiologists navigate tortuous anatomies, while minimizing trauma with distal softness and microwire tracking.
“Interventional radiologists are at the forefront of advancing minimally invasive procedures and play a critical role in improving patient outcomes,” said Dan Sirota, vice president and global leader of Cook Medical’s Interventional Radiology division. “As a leader in embolic therapies, Cook Medical is proud to provide interventional radiologists with tools like Cantata to advance their field of medicine.”
Accepting .018 inch embolization coils, the Cantata allows coil delivery and can be used in combination with a wide range of emobolization products, including Cook Medical’s MicroNester® and Tornado® Microcoils™. Designed to be Lipiodol® and dimethyl sulfoxide (DMSO) compatible, the Cantata microcatheter can be used in a range of procedures. The kink-resistant braided construction along the entire length of the shaft provides improved torque response and trackability for vessel selection while maintaining catheterization. With a hydrophilic coating designed to reduce surface friction, the 2.8 and the 2.5 French catheter lines can achieve a flow rate as high as 3.5 mL/sec and 1.6 mL/sec, respectively. The five durometer zones, more than any other microcatheter, deliver a distinct yet seamless transition from the shaft to the soft, distal tip, reducing the risk of trauma.
The Cantata Superselective Microcatheter received U.S. Food and Drug Administration clearance in December of 2010.
About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.Cookmedical.com. Follow Cook Medical on Twitter @Cookmedicalpr and @Cook_ir.
Source: Cook Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.